Please try another search
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company’s products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.
Name | Age | Since | Title |
---|---|---|---|
Staffan E. Encrantz | 69 | 2017 | Independent Chairman |
David Badawi | 51 | 2011 | Founder, CTO & Director |
Donald J. Zurbay | 53 | 2020 | Independent Director |
Erica J. Rogers | 57 | 2019 | Independent Director |
Paul Badawi | 46 | 2011 | Co-Founder, President, CEO & Director |
Brenda Becker | 63 | 2022 | Independent Director |
Tamara R. Fountain | 60 | 2022 | Independent Director |
Catherine Mazzacco | 58 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review